Medicamen Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory compliance filing related to the company's dealings with depositories (such as NSDL or CDSL) and their participants. No specific financial figures, share counts, or material business details were disclosed in the announcement. The filing typically relates to either a dematerialization compliance certificate or an audit/secretarial certification required periodically by SEBI norms.
This is a procedural compliance filing and is unlikely to have any direct impact on the stock price or shareholder value. It signals that the company is meeting its routine regulatory obligations regarding share depository operations.